Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.1% Today

What is Teladoc Health Inc.?

Teladoc Health (TDOC) is a leading telemedicine company that provides virtual healthcare services to patients worldwide. The company offers a range of services, including virtual urgent care, chronic care management, and mental health support.

Why is Teladoc Health Inc. going down?

TDOC stock is down 5.1% on Jan 27, 2026 15:21

• Despite offering free non-emergency care to Texans affected by the recent winter storm, Teladoc Health (TDOC) experienced a strong bearish movement in the market.
• Investor caution and concerns about user trends and profitability have led to significant share price declines over the past year, even though the stock is trading at a notable discount to its intrinsic value and analyst targets.
• The company's recent upgrades to its 24/7 Care service, including expanded virtual urgent care and specialist input, have not been sufficient to offset the market's worries about future growth concerns and chronic care contracts.
• While Teladoc's data-driven expansion strategy aims to solidify its position in virtual care competition, challenges like weak user growth and ongoing losses continue to weigh on the stock's performance, leaving investors cautious about its long-term prospects.

TDOC Price Chart

TDOC Technical Analysis

TDOC News

Teladoc offers free non-emergency care for Texans impacted by winter storm

Teladoc Health has activated its Natural Disaster Hotline in Texas to provide free non-emergency medical care to those affected by the recent winter storm. This service covers common ailments like cold and flu symptoms, sinus issues, and respiratory infections, and is available to everyone regardless of their Teladoc membership status or health plan. Teladoc can also prescribe medications and refills when medically necessary, emphasizing the need for current members to use the hotline specifically for these complimentary services.

https://cw33.com/news/local/teladoc-offers-free-non-emergency-care-for-texans-impacted-by-winter-storm/

Assessing Teladoc Health (TDOC) Valuation As Investor Caution Grows Despite Product Updates

Teladoc Health (TDOC) has upgraded its 24/7 Care service despite investor concerns regarding user trends and profitability, leading to significant share price declines over the past year. While the stock is trading at a notable discount to its intrinsic value and analyst targets, its future valuation depends on stabilizing its BetterHelp service and maintaining chronic care contracts. The article suggests investors can build their own Teladoc Health narrative using available tools to assess potential investments.

https://www.sahmcapital.com/news/content/assessing-teladoc-health-tdoc-valuation-as-investor-caution-grows-despite-product-updates-2026-01-23

Assessing Teladoc Health (TDOC) Valuation As Investor Caution Grows Despite Product Updates

Teladoc Health (TDOC) has recently upgraded its 24/7 Care service, expanding virtual urgent care and integrating specialist input, despite a significant decline in its share price over the past year. The company's stock is currently trading at a 54% discount to its intrinsic estimate and 42% below analyst targets, raising questions about whether it is mispriced or if the market is correctly accounting for future growth concerns. Analysts point to Teladoc's international expansion and long-term chronic care as key drivers for its valuation.

https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/assessing-teladoc-health-tdoc-valuation-as-investor-caution

Is Teladoc’s Expanded 24/7 Care Data Strategy a Durable Edge in Virtual Care Competition (TDOC)?

Teladoc Health recently expanded its 24/7 Care virtual urgent care service, integrating broader condition coverage, real-time prescription benefit checks, and links to other programs through its Prism platform. This data-driven expansion aims to solidify Teladoc's position in hybrid care, tying urgent care to preventive screenings and chronic condition support. While seen as an incremental product improvement rather than a quick revenue catalyst, it's crucial for Teladoc's long-term strategy amidst challenges like weak user growth and ongoing losses.

https://nz.finance.yahoo.com/news/teladoc-expanded-24-7-care-211446821.html

Is Teladoc (TDOC) Now Offering Value After Multi‑Year Share Price Declines

Teladoc Health (NYSE: TDOC) has seen significant share price declines over multiple years. Despite this, a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 54.8%, with an estimated intrinsic value of US$13.62 per share compared to its current price of US$6.16. Additionally, its Price-to-Sales (P/S) ratio of 0.43x is considerably lower than the industry average of 2.23x and Simply Wall St's Fair Ratio of 1.99x, further indicating undervaluation.

https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/is-teladoc-tdoc-now-offering-value-after-multiyear-share-pri

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Up 6.6% Today

Solana ($SOL) Crypto Forecast: Up 6.3% Today

Ethereum ($ETH) Crypto Forecast: Up 5.2% Today

Hasbro Inc. ($HAS) Stock Forecast: Up 5.0% Today

Cardano ($ADA) Crypto Forecast: Up 5.6% Today

MicroVision Inc. ($MVIS) Stock Forecast: Down 5.8% Today

Western Digital Corporation ($WDC) Stock Forecast: Up 7.9% Today

GameStop Corp. ($GME) Stock Forecast: Up 5.1% Today

Intel Corporation ($INTC) Stock Forecast: Up 5.4% Today

Monolithic Power Systems Inc. ($MPWR) Stock Forecast: Up 5.1% Today

Teladoc Health Inc. Price History

15.00.2026 - TDOC Stock was down 6.1%

• Despite recent upgrades to its 24/7 Care service and virtual urgent care expansion, Teladoc Health's stock faced bearish movement today.
• The market's negative reaction may stem from concerns about the company's share price weakness and perceived undervaluation, marked by an estimated fair value of US$9.13.
• While unveiling new treatment capabilities and enhancing patient care, Teladoc Health faces investor caution regarding churn management and market competition.
• The bearish trend could also be influenced by broader market factors or investor sentiment towards the telemedicine sector, despite optimistic growth projections for the industry.

13.10.2025 - TDOC Stock was down 5.0%

• Teladoc Health (TDOC) experienced a bearish movement today, possibly influenced by the wider year-over-year loss in Q3, particularly due to the struggles of its BetterHelp unit.
• Despite gains in international revenues and efforts to expand AI-powered virtual care capabilities, the market may have reacted negatively to the disappointing performance of a key segment.
• The announcement of an employee inducement award may not have been sufficient to offset concerns about the company's financial performance, leading to the bearish trend in TDOC stock.
• As competitors like Hims & Hers enhance their technology-enabled care models and new offerings, investors might be reevaluating Teladoc Health's position in the telemedicine market, contributing to the downward movement in its stock price.

06.00.2026 - TDOC Stock was up 8.5%

• The participation of Teladoc Health's CEO in the 44th Annual J.P. Morgan Healthcare Conference likely boosted investor confidence in the company's future prospects and growth opportunities.
• The optimistic forecast for the "Online Doctor Consultations Market" and Teladoc Health's recognition as a key player in the sector might have influenced the bullish trend.
• Despite encountering obstacles in the post-pandemic market and facing doubts from financial analysts, Teladoc Health's endeavors to enhance profitability and broaden partnerships appear to be well-received by investors, propelling the stock upwards.
• In conclusion, the positive impact of the CEO's conference involvement, market growth predictions, and strategic measures to address past concerns possibly drove the bullish movement in Teladoc Health's stock.

06.10.2025 - TDOC Stock was down 5.8%

• Q3 results surpassed expectations, yet the stock saw significant bearish activity.
• Revenues declined and losses increased, notably attributed to underperformance at BetterHelp, impacting the market sentiment negatively.
• Concerns among investors about sustaining growth and profitability amid these difficulties likely led to the stock price decline.

18.10.2025 - TDOC Stock was up 5.2%

• TDOC's bullish movement today can be attributed to its accelerated global expansion efforts.
• The company's focus on expanding international operations and increasing overseas revenues is boosting its profitability outlook, which is likely driving investor confidence and pushing the stock price higher.
• The market is responding favorably to TDOC's strategic initiatives to tap into new markets and capitalize on the growing demand for telehealth services, positioning the company for long-term success in the evolving healthcare industry.

23.11.2025 - TDOC Stock was down 5.5%

• A financial institution initiated coverage on Teladoc with an Equal Weight rating and a price target of $8.50, reflecting a neutral outlook on the industry.
• Despite potential undervaluation according to certain analyses like the DCF model and a low Price to Sales ratio, mixed user growth metrics and possible competition in the telehealth market raised investor concerns, leading to a bearish trend.
• The announcement of a board director's retirement in 2026 raised questions about the company's future leadership and strategic direction, impacting the stock sentiment negatively.
• The filing for a potential issuance of $13.6 million in common stock for an employee stock ownership plan, along with a reassessment of the company's valuation, prompted investors to scrutinize further, contributing to the bearish movement in the stock.

14.00.2026 - TDOC Stock was down 5.3%

• Today's downward movement in TDOC stock may stem from profit-taking by investors following a period of strong growth. Teladoc Health recently garnered recognition as "Best in Business 2025" for its contributions to telehealth.
• Despite introducing new capabilities to treat a broader array of conditions and enhance care coordination, there are concerns in the market about the company's ability to maintain its competitive position in the evolving telemedicine landscape.
• Projections point to a bright long-term future for the telemedicine sector, estimated to reach $488.89 billion by 2033, indicating significant growth potential for companies like Teladoc Health. However, short-term market volatility and investor sentiment could influence stock performance in the near term.
• In conclusion, while Teladoc Health's strategic expansions and progress in virtual care services show promise, market conditions and investor expectations likely played a role in today's decline in TDOC stock.

27.00.2026 - TDOC Stock was down 5.1%

• Despite offering free non-emergency care to Texans affected by the recent winter storm, Teladoc Health (TDOC) experienced a strong bearish movement in the market.
• Investor caution and concerns about user trends and profitability have led to significant share price declines over the past year, even though the stock is trading at a notable discount to its intrinsic value and analyst targets.
• The company's recent upgrades to its 24/7 Care service, including expanded virtual urgent care and specialist input, have not been sufficient to offset the market's worries about future growth concerns and chronic care contracts.
• While Teladoc's data-driven expansion strategy aims to solidify its position in virtual care competition, challenges like weak user growth and ongoing losses continue to weigh on the stock's performance, leaving investors cautious about its long-term prospects.

20.10.2025 - TDOC Stock was up 5.1%

• The partnership with TytoCare to expand at-home exam capabilities indicates Teladoc Health's commitment to offering comprehensive virtual care solutions, which likely boosted investor confidence in the stock.
• Teladoc Health's efforts to accelerate global expansion and increase international operations have contributed to a positive outlook for the company's profitability, driving investor interest and pushing the stock price higher.
• The bullish movement in TDOC's stock can be attributed to the market's positive reception of the company's strategic initiatives to broaden its services and geographical presence, positioning it for sustained growth in the telemedicine sector.

07.00.2026 - TDOC Stock was down 5.0%

• Today's decline in TDOC's stock price may be linked to cautious investor sentiment surrounding concerns about competition, revenue diversification, and net losses affecting the company's valuation.
• The publication outlining reasons to steer clear of investing in Teladoc Health stock likely contributed to the negative sentiment among investors, prompting a selloff.
• The CEO of Teladoc Health is set to participate in the J.P. Morgan Healthcare Conference, where insights into the company's strategies for addressing current challenges are anticipated by investors.

07.10.2025 - TDOC Stock was down 5.4%

• Concerns have emerged regarding potential increases in operating expenses or share dilution following the announcement of an employee inducement award, which may have led to the bearish sentiment.
• Despite exceeding Q3 earnings expectations, declines in revenues and increasing losses, particularly related to underperformance at BetterHelp, likely contributed to the negative market response.
• Investor apprehension about sustaining growth and profitability in the face of challenges within specific business segments may have triggered the sell-off of TDOC shares.

30.09.2025 - TDOC Stock was up 5.3%

• Teladoc Health surpassed revenue expectations for the third quarter, demonstrating strong performance in the telehealth sector.
• Despite mixed results, the market responded positively to Teladoc's overall performance, pushing the stock price higher.
• The bullish movement may reflect investors' confidence in Teladoc's potential to benefit from the increasing demand for telehealth services, particularly during the current global health crisis.